T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy

S.J.A.M. Santegoets, A.J.M. van den Eertwegh, A.G.M. Stam, R.J. Scheper, S.M. Lougheed, P.E. Scholten, B.M.E. von Blomberg, H. Gall, K. Jooss, N. Sacks, T. Harding, K. Hege, I. Lowy, W.R. Gerritsen, T.D. de Gruijl

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)918-919
JournalJournal of Immunotherapy
Issue number8
Publication statusPublished - 2010

Cite this